Diaverum today announced the opening of its first clinic in Kyrgyzstan, marking an important step in expanding access to high-quality, life-enhancing renal care across Central Asia.
Located in Bishkek, Kyrgyzstan’s capital and largest city, the opening of the new clinic is the result of a cooperation with the Government of the Kyrgyz Republic, offering state-funded dialysis for eligible patients. The collaboration reflects a shared commitment to expanding access to specialist, life-sustaining renal care and addressing the growing burden of chronic kidney disease (CKD) in the country.
The clinic’s official inauguration was hosted by Amantur Ryskulov, General Manager, Diaverum Southeast Asia and Central Asia, and attended by Ziyad Kabli, Chief Operations Officer, M42 Middle East and Asia, together with other members of the regional leadership team at M42; Mohamed Salmeen, Head of Support Services, Consular Affairs and Nationals Services Section at the UAE Embassy in Bishkek; Nurlan Mamyrov, Honorary Consul of Sweden to the Kyrgyz Republic; the management of the Ministry of Health of the Kyrgyz Republic and the National Investment agency under the President of the Kyrgyz Republic, as well as senior representatives from public health authorities and other government bodies.
CKD represents a significant public health challenge in Kyrgyzstan, with recent research indicating a prevalence of 10.8% among the country's adult population. This highlights the need for accessible, high-quality kidney care and earlier intervention.
The Bishkek clinic will open with 15 dialysis stations operating across three shifts from Monday to Saturday, with capacity to expand to 20 stations over time. It will introduce Diaverum's established patient-centred care model, supported by strong clinical governance and operational expertise to deliver high-quality haemodialysis services. The opening also creates a platform for broader collaboration with healthcare authorities across prevention, earlier intervention, home-based therapies and the management of comorbidities as the country’s renal care needs evolve.
Rooted in its Swedish healthcare heritage and guided by its True care culture, Diaverum combines international clinical standards with local expertise to deliver safe, personalised and compassionate renal care, supporting patients to live fulfilling lives. Diaverum brings more than 35 years of international renal care expertise and today operates in 26 countries across Europe, Latin America, the Middle East and Asia, caring for more than 47,000 patients across over 460 clinics.
Diaverum’s entry into Kyrgyzstan coincides with the 10th anniversary of its operations in neighbouring Kazakhstan, where Diaverum has grown to become the country's largest private dialysis provider, with a nationwide network of 55 clinics caring for more than 3,400 patients.
As part of M42, a global health leader powered by artificial intelligence (AI), technology, and genomics, Diaverum is connected to a wider healthcare ecosystem spanning advanced patient care, digital health and integrated health solutions.
Rafael Romanini, Chief Executive Officer of Diaverum, said: "Kyrgyzstan represents an important new chapter in Diaverum's international journey. Our entry into the country reflects a long-term commitment to supporting the evolution of kidney care through trusted partnerships, clinical excellence and knowledge sharing. We look forward to contributing to the continued development of renal services and creating lasting value for patients, healthcare professionals and the wider health system."
Amantur Ryskulov, Regional General Manager for South East Asia and Central & East Asia at Diaverum, said: "The opening of our first clinic in Bishkek establishes the foundation for Diaverum's long-term presence in Kyrgyzstan. Building on our experience across Central Asia and internationally, we look forward to working closely with government, healthcare professionals and local communities to strengthen kidney care from high-quality dialysis and earlier intervention to better management of chronic kidney disease. Above all, our ambition is to help people living with kidney disease live fulfilling lives.
